| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 9.58 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
The following paper focuses on the development of an investment thesis and are spective value creation strategy for the potential leveraged buy out of Derma pharm Holding SE, a German developer, producer, and distributor of niche prescription and over-the-counter pharmaceuticals. Qualitatively, it evaluates the address able market of Derma pharm, its segmentation, main competitors, and main trends, specifically separated by the three main business segments. Quantitatively, it quantifies the total address able markets and main trends
Descrição
Palavras-chave
Private equity challenge Corporate finance Private equity Leveraged buyout Market overview Field lab Specialty pharmaceuticals & generics
